Safety Evaluation of Inhaled Treprostinil Administration Following Transition From Inhaled Ventavis in PAH Subjects
| Status: | Archived |
|---|---|
| Conditions: | High Blood Pressure (Hypertension) |
| Therapuetic Areas: | Cardiology / Vascular Diseases |
| Healthy: | No |
| Age Range: | Any |
| Updated: | 7/1/2011 |
| Start Date: | September 2008 |
| End Date: | September 2010 |
An Open Label, Multi-Center Study Evaluating the Safety of Long-Term Inhaled Treprostinil Sodium Administration Following Transition From Inhaled Ventavis® (Iloprost) in Subjects With Pulmonary Arterial Hypertension.
This is a 24-month, multi-center, prospective, open-label, safety evaluation in PAH subjects
following transition from a stable dose of inhaled iloprost (Ventavis).
Subjects are to be evaluated for safety throughout the course of the study while secondary
assessments will be conducted at Baseline, Week 6, Week 12, and Months 6, 12, 18 and 24
following initiation of treprostinil sodium.
We found this trial at
10
sites
Click here to add this to my saved trials
1240 North Mission Road # L919
Los Angeles, California 90033
Los Angeles, California 90033
Click here to add this to my saved trials
1211 Medical Center Dr
Nashville, Tennessee 37232
Nashville, Tennessee 37232
(615) 322-5000
Vanderbilt Univ Med Ctr Vanderbilt University Medical Center (VUMC) is a comprehensive healthcare facility dedicated...
Click here to add this to my saved trials
Click here to add this to my saved trials
Duke Univ Med Ctr As a world-class academic and health care system, Duke Medicine strives...
Click here to add this to my saved trials
Click here to add this to my saved trials
Long Island Jewish Medical Center Serving North Shore LIJ Health System employees and their families....
Click here to add this to my saved trials
Columbia Presbyterian Med Ctr On January 1, 1998, The New York Hospital publicly announced its...
Click here to add this to my saved trials
Click here to add this to my saved trials
Click here to add this to my saved trials